The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom ...
The FDA said Fresenius Kabi told customers to remove its Ivenix large-volume infusion pumps from use for repair.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback